Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
AFT PHARMACEUTICALS LIMITED,Sirolimus (Rapamycin),Facial angiofibromas associated with Tuberous Sclerosis Complex,Sirolimus (Rapamycin) (Pascomer),Options for investment,Community,
